The antifungal drug isavuconazole inhibits the replication of human cytomegalovirus (HCMV) and acts synergistically with anti-HCMV drugs.

MLA

Mercorelli, Beatrice, et al. “The Antifungal Drug Isavuconazole Inhibits the Replication of Human Cytomegalovirus (HCMV) and Acts Synergistically with Anti-HCMV Drugs.” Antiviral Research, vol. 189, May 2021, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.antiviral.2021.105062.

APA

Mercorelli, B., Celegato, M., Luganini, A., Gribaudo, G., Lepesheva, G. I., & Loregian, A. (2021). The antifungal drug isavuconazole inhibits the replication of human cytomegalovirus (HCMV) and acts synergistically with anti-HCMV drugs. Antiviral Research, 189, N.PAG. https://doi.org/10.1016/j.antiviral.2021.105062

Chicago

Mercorelli, Beatrice, Marta Celegato, Anna Luganini, Giorgio Gribaudo, Galina I. Lepesheva, and Arianna Loregian. 2021. “The Antifungal Drug Isavuconazole Inhibits the Replication of Human Cytomegalovirus (HCMV) and Acts Synergistically with Anti-HCMV Drugs.” Antiviral Research 189 (May): N.PAG. doi:10.1016/j.antiviral.2021.105062.